CSBR
Champions Oncology
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: CSBR
- PE Ratio
The current PE ratio of CSBR cannot be calculated, as the latest EPS of -$0.17 is negative. The most recent PE ratio recorded for Champions Oncology was 38.0 in October 2025.
CSBR PE ratio history
Over the last eight years, the average PE ratio of Champions Oncology has been 360.38. Looking back at the last eight years, CSBR's PE ratio peaked in the Jul 2021 quarter at 1,045, with a price of $10.45 and an EPS of $0.01. The Apr 2025 quarter marked the lowest point at 21.03, with a price of $7.15 and an EPS of $0.34.
Champions Oncology PE ratio by year
Maximum annual decrease: -46.32% in 2022
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 21.03 | N/A | $7.15 | $0.34 |
| 2024 | N/A | N/A | $4.85 | -$0.54 |
| 2023 | N/A | N/A | $4.92 | -$0.39 |
| 2022 | 192 | -46.32% | $7.68 | $0.04 |
| 2021 | 357.67 | N/A | $10.73 | $0.03 |
| 2020 | N/A | N/A | $7.72 | -$0.18 |
| 2019 | 908 | N/A | $9.08 | $0.01 |
| 2018 | N/A | N/A | $4.34 | -$0.13 |
| 2017 | N/A | N/A | $2.65 | -$0.64 |
| 2016 | N/A | N/A | $3.85 | -$1.2 |
| 2015 | N/A | N/A | $7.32 | -$2.2 |
| 2014 | N/A | N/A | $10.92 | -$1.33 |
| 2013 | N/A | N/A | $5.28 | -$1.44 |
| 2012 | N/A | N/A | $8.04 | -$2.28 |
| 2011 | N/A | N/A | $12 | -$1.32 |
Champions Oncology PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Jan 2026 | N/A | N/A | $7.31 | -$0.17 |
| Oct 2025 | 38 | 26.25% | $6.84 | $0.18 |
| Jul 2025 | 30.1 | 43.13% | $6.32 | $0.21 |
| Apr 2025 | 21.03 | -10.05% | $7.15 | $0.34 |
| Jan 2025 | 23.38 | N/A | $10.99 | $0.47 |
| Oct 2024 | N/A | N/A | $3.91 | -$0.05 |
| Jul 2024 | N/A | N/A | $4.79 | -$0.25 |
| Apr 2024 | N/A | N/A | $4.85 | -$0.54 |
| Jan 2024 | N/A | N/A | $5.81 | -$0.72 |
| Oct 2023 | N/A | N/A | $5.46 | -$0.71 |
| Jul 2023 | N/A | N/A | $6.5 | -$0.56 |
| Apr 2023 | N/A | N/A | $4.92 | -$0.39 |
| Jan 2023 | N/A | N/A | $4.11 | -$0.23 |
| Oct 2022 | 694 | 140.41% | $6.94 | $0.01 |
| Jul 2022 | 288.67 | 50.35% | $8.66 | $0.03 |
CSBR Price vs fair value
CSBR average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
PE comparison
CSBR PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| EXEL Exelixis Inc | 16.83 | $13.2B |
| CRL Charles River Laboratories International Inc | N/A | $8.95B |
| CLDX Celldex Therapeutics Inc | N/A | $2.35B |
| CSBR Champions Oncology Inc | N/A | $79.99M |
Frequently asked questions
What is Champions Oncology's PE ratio?
The current price to earnings ratio of CSBR cannot be determined, as its EPS of -$0.17 is negative.
What is the 5-year average PE ratio for Champions Oncology (CSBR)?
The 5-year average price to earnings ratio for CSBR stock is 305.89.
What is the highest PE ratio for CSBR?
The highest quarterly PE ratio in the last eight years has been 1,045 and it was in the Jul 2021 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.